| 04/10/2024 15:35 |
Notice Regarding Change of Major Shareholder |
| 04/01/2024 15:30 |
Notice regarding acquisition and acquisition completion of Treasury Stock |
| 03/15/2024 15:30 |
Notice Regarding Personnel Changes |
| 03/15/2024 15:30 |
Notice of the Candidates for Board Directors |
| 03/08/2024 15:30 |
Notice regarding acquisition of Treasury Stock |
| 02/15/2024 15:00 |
Notice Regarding Receiving Manufacturing and Marketing Approval for Additional Formulation, Madopar L50 Combination Tablets |
| 02/09/2024 15:30 |
Notice regarding acquisition of Treasury Stock |
| 02/02/2024 12:00 |
Consolidated Financial Result Digest FY2024/3 Q3 (Fiscal Year Ended March 31, 2024) |
| 02/02/2024 12:00 |
Consolidated Financial Results for the First Nine Months of the Fiscal Year Ended March 31, 2024 |
| 01/10/2024 15:30 |
Notice regarding acquisition of Treasury Stock |
| 12/08/2023 15:30 |
Notice regarding acquisition of Treasury Stock |
| 11/10/2023 15:30 |
Notice regarding acquisition of Treasury Stock |
| 11/06/2023 12:00 |
Consolidated Financial Result Digest FY2024/3 Q2 (Fiscal Year Ended March 31, 2024) |
| 11/06/2023 12:00 |
Notice of Differences between Earnings Forecasts and Financial Results and Revised Earnings Forecasts |
| 11/06/2023 12:00 |
Consolidated Financial Results for the First Six Months of the Fiscal Year Ended March 31, 2024 |
| 10/10/2023 15:30 |
Notice regarding acquisition of treasury stock |
| 10/10/2023 15:30 |
[Delayed]Corporate Governance Report |
| 09/14/2023 12:00 |
Notice regarding personnel changes |
| 09/14/2023 12:00 |
Notice regarding change in responsibility of the director |
| 09/14/2023 12:00 |
Notice Regarding Transition to Company with Audit & Supervisory Committee |
| 09/08/2023 15:30 |
Notice regarding acquisition of treasury stock |
| 08/10/2023 15:30 |
Notice regarding acquisition of treasury stock |
| 08/01/2023 12:00 |
Consolidated Financial Result Digest FY2024/3 1Q (Fiscal Year Ending March 31, 2024) |
| 08/01/2023 12:00 |
Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024 |
| 07/14/2023 15:30 |
Notice Regarding Completion of Payment for New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System |
| 07/10/2023 15:30 |
[Delayed]Notice Regarding Issuance of New Shares as Restricted Stock Compensation System and Performance-Linked Stock Compensation System |
| 06/27/2023 12:00 |
Notice regarding personnel changes |
| 06/19/2023 08:30 |
Matters Concerning Controlling Shareholders, Etc. |
| 06/19/2023 08:30 |
Notice regarding personnel changes |
| 05/12/2023 12:00 |
Notice regarding personnel changes |
| 05/12/2023 12:00 |
Notice regarding changes in responsibility of directors |
| 05/01/2023 15:30 |
Notice regarding introduction of entrusted Executive Officer system |
| 05/01/2023 12:00 |
Notice Regarding Acquisition Plan of Treasury Stock |
| 05/01/2023 12:00 |
Consolidated Financial Result Digest FY2022 Q4 (Fiscal Year Ended March 31, 2023) |
| 05/01/2023 12:00 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 |
